Menu

In the News

January 20, 2026 • Press Releases

Global Alzheimer’s Platform Foundation Applauds Congressional Funding Increase for Alzheimer’s Research

Washington D.C., Jan 20, 2026, The Global Alzheimer’s Platform Foundation® (GAP) applauds the House and Senate Committees on appropriations releasing their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill which increases funding for Alzheimer’s disease and other dementia research.     “Congress’s bipartisan approval of increased funding for neurodegenerative research sends a powerful message to the millions of […]

Alzheimer's Alzheimers GAP Innovation Research
January 19, 2026 • In the News

The Independent: The finger prick blood test that could revolutionise Alzheimer’s diagnosis

The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]

Alzheimer's Alzheimers Bio-Hermes Bio-Hermes-002 GAP LifeArc Research
January 19, 2026 • In the News

LifeArc: Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer’s disease before symptoms begin

A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain […]

Alzheimer's Alzheimers Bio-Hermes-002 biomarkers GAP Research
January 18, 2026 • In the News

Providence Business News: Providence research company seeking participants for Alzheimer’s study

  By Jacquelyn Voghel 01/18/2026 EAST PROVIDENCE – A national research institution’s Rhode Island location is calling for volunteers with Alzheimer’s disease to participate in a study attempting to identify predictive markers of the brain condition. K2 Medical Research – East Providence has begun enrolling participants in the Bio-Hermes 002 Study, an initiative of the Global Alzheimer’s Platform Foundation. The study seeks […]

Alzheimer's Alzheimers Bio-Hermes-002 biomarkers GAP Research
January 12, 2026 • In the News

K2 Medical Research Providence Seeking Participants for Observational Study   

K2 Now Enrolling in Innovative Study of Alzheimer’s Blood and Digital Biomarker Tests; Research Volunteers Receive No-Cost Brain Scan and Learn About Their Brain Health  East Providence, RI- Jan 12, 2026 – – K2 Medical Research in Rhode Island has started enrolling volunteers with memory concerns in the Global Alzheimer’s Platform Foundation® (GAP)’s innovative Bio-Hermes-002 Study to […]

January 12, 2026 • Press Releases

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Spear Bio for the Transformative Bio-Hermes-002 Study

Spear Bio joins collaborative study focused on new biomarkers designed to improvediagnosis of Alzheimer’s disease and dementias  Washington D.C., Jan 12, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform […]

Alzheimer's Alzheimers Bio-Hermes-002 GAP Research Spear Bio
January 9, 2026 • Press Releases

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies

Washington D.C., Jan 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of clinical […]

Alzheimer's Alzheimers Bio-Hermes Bio-Hermes-002 biomarkers GAP Research
December 23, 2025 • Press Releases

Clinical Neurology Specialists Partnering with Leading International Nonprofit to Accelerate Alzheimer’s Research in Las Vegas

Collaboration to Improve Access to Study for Alzheimer’s Disease Las Vegas, Nev. – Dec. 23 2025 – Today, Global Alzheimer’s Platform Foundation® (GAP) and Clinical Neurology Specialists (CNS) announced their collaboration to accelerate Alzheimer’s disease research in Las Vegas. CNS has joined the GAP-sponsored study, Bio-Hermes-002, a unique, observational platform study that compares blood-based and digital biomarkers […]

Alzheimer's Alzheimers Bio-Hermes-002 CNS GAP Research
December 20, 2025 • In the News

WPBF: ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings

20 Dec ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings Posted at 20:23h in Uncategorized by Belinda Russell 0 Comments ATLANTIS, Fla. — It’s the holiday season and while you celebrate with friends and family some experts say you may also notice some changes in elderly loved ones you haven’t seen for a while. Dr. Linda […]

Alzheimer's Alzheimers Bio-Hermes biomarkers GAP Research
December 10, 2025 • In the News

Think Global Health: A New Era for Alzheimer’s Disease Diagnosis

Aging Emerging biomarkers and digital tools are unlocking earlier and more accurate diagnosis Teresa, 75, an Alzheimer’s patient and former businesswoman, poses for a photograph inside the Alzheimer Foundation, in Mexico City, Mexico, on April 19, 2012.REUTERS/Edgard Garrido by Lydia Wu, Jennifer Panlilio, Melissa Lee, Laura Nisenbaum, Aishu Sukumar December 10, 2025 Alzheimer’s disease and related dementias affect more than […]

Alzheimer's Alzheimers Bio-Hermes biomarkers GAP Innovation Research